Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Nowcasting and Forecasting the Spread of COVID-19 and Healthcare Demand In Turkey, A Modelling Study

View ORCID ProfileAbdullah Uçar, View ORCID ProfileŞeyma Arslan, View ORCID ProfileYusuf Özdemir
doi: https://doi.org/10.1101/2020.04.13.20063305
Abdullah Uçar
1Istanbul University, Health Sciences Institute, Public Health Department
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abdullah Uçar
Şeyma Arslan
2Istanbul University, Istanbul Medical Faculty, Public Health Department
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Şeyma Arslan
  • For correspondence: seyma.arslan@istanbul.edu.tr
Yusuf Özdemir
3Queen Mary University of London, Centre for Primary Care and Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yusuf Özdemir
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background A new type of coronavirus (later named Sars-Cov-2) drew attention in 31 December 2019 after the reporting of 27 unidentified pneumonia cases detected in Wuhan, China to the World Health Organization (WHO). Rapid progression of the COVID-19 pandemic has revealed the necessity of epidemic modeling studies to evaluate the course of the epidemic and its burden on the health system. This study aims to estimate the total number of infected people, evaluate the consequences of social interventions on the healthcare system and predict the expected number of cases, intensive care needs, hospitalizations and mortality rates in Turkey according to possible scenarios via the SEIR-based epidemic modeling method.

Methods This study was carried out in three dimensions. In the first, the actual number of people infected in the community has been estimated using the number of deaths in Turkey. In the second, the expected total numbers of infected people, total deaths, total hospitalizations, and intensive care unit (ICU) bed needs have been predicted in case of no intervention. In third, distribution of the expected number of infected people and deaths, ICU and non-ICU bed needs over time has predicted based on SEIR modelling. A simulator (TURKSAS) has been developed and predictions made in 4 scenarios for Turkey.

Results According to deaths, estimated number of infected people in Turkey on March 21 was 123,030.In the case of no intervention (1st scenario) the expected total number of infected people is 72,091,595, the total number of deaths is 445,956, the attack rate is 88.1%, the mortality ratio is 0.54%. The ICU bed capacity in Turkey is expected to exceed 4.4-fold and non-ICU bed capacity exceed 3.21-fold. In 2nd and 3rd scenario according to the calculations made by considering the social compliance rates of the NPIs, the value of R0 is estimated to decrease from 3 to 1.38 level. Compliance with NPIs makes a 94,303 difference in the expected number of deaths. In both scenarios, the predicted peak value of occupied ICU and non-ICU beds remains below the Turkey’s capacity. While this study conducted, curfew for >65 and <20 age groups was in force in Turkey. If the curfew is declared for the 21-64 age population (4th scenario), the R0 value drops below 1 (0.98), the expected deaths are 14,230 and the peak values of daily ICU and non-ICU bed demand are below the country’s capacity.

Discussion Modeling epidemics with assumptions supported by scientific literature and establishing decision support systems based on objective criteria is an important requirement. According to scientific data for the population of Turkey, the situation is not expected to be of worse than predictions presented in the second dimension. Predictions show that 16 million people can be prevented from being infected and 100,000 deaths can be prevented by full compliance with the measures taken. Complete control of the pandemic is possible by keeping R0 below 1. For this, additional evidence-based measures are needed.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We declare this study funded by authors.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We used external data from: 1) TurkStat data 2) Turkey Health Statistics

http://tuik.gov.tr/PreIstatistikTablo.do?istab_id=1632

https://www.saglik.gov.tr/TR,62400/saglik-istatistikleri-yilligi-2018-yayinlanmistir.html

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 17, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Nowcasting and Forecasting the Spread of COVID-19 and Healthcare Demand In Turkey, A Modelling Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Nowcasting and Forecasting the Spread of COVID-19 and Healthcare Demand In Turkey, A Modelling Study
Abdullah Uçar, Şeyma Arslan, Yusuf Özdemir
medRxiv 2020.04.13.20063305; doi: https://doi.org/10.1101/2020.04.13.20063305
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Nowcasting and Forecasting the Spread of COVID-19 and Healthcare Demand In Turkey, A Modelling Study
Abdullah Uçar, Şeyma Arslan, Yusuf Özdemir
medRxiv 2020.04.13.20063305; doi: https://doi.org/10.1101/2020.04.13.20063305

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (110)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8989)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1959)
  • Geriatric Medicine (190)
  • Health Economics (402)
  • Health Informatics (1329)
  • Health Policy (660)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10809)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1830)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (999)
  • Ophthalmology (298)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (580)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1904)
  • Public and Global Health (4123)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (549)
  • Rheumatology (225)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (81)